
Abbott Laboratories
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Connect with us at abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube. About Flatiron Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients' real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. SOURCE Abbott
A large-cap company with a $178.9B market cap.
Current Price
$102.87
+0.48%GoodMoat Value
$72.81
29.2% overvaluedAbbott Laboratories (ABT) Stock News
ABT Stock News & Headlines
Latest stock news and headlines for Abbott Laboratories (ABT). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $102.87. Market cap: $178.88B. Sector: Healthcare. Industry: Medical Devices. This page aggregates the latest news articles relevant to ABT from financial news sources, helping investors stay current on events that may impact Abbott Laboratories's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Abbott Laboratories (ABT).